SIRIUSPOINT LTD (SPNT) Fundamental Analysis & Valuation

NYSE:SPNT • BMG8192H1060

20.61 USD
-0.1 (-0.48%)
At close: Mar 10, 2026
20.61 USD
0 (0%)
After Hours: 3/10/2026, 8:04:00 PM

This SPNT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to SPNT. SPNT was compared to 149 industry peers in the Insurance industry. While SPNT is still in line with the averages on profitability rating, there are concerns on its financial health. SPNT is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. SPNT Profitability Analysis

1.1 Basic Checks

  • In the past year SPNT was profitable.
  • SPNT had a positive operating cash flow in the past year.
  • Of the past 5 years SPNT 4 years were profitable.
  • SPNT had a positive operating cash flow in each of the past 5 years.
SPNT Yearly Net Income VS EBIT VS OCF VS FCFSPNT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M -400M

1.2 Ratios

  • The Return On Assets of SPNT (3.53%) is better than 67.79% of its industry peers.
  • SPNT's Return On Equity of 17.94% is fine compared to the rest of the industry. SPNT outperforms 77.85% of its industry peers.
  • With a Return On Invested Capital value of 2.76%, SPNT perfoms like the industry average, outperforming 53.69% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for SPNT is significantly below the industry average of 15.25%.
Industry RankSector Rank
ROA 3.53%
ROE 17.94%
ROIC 2.76%
ROA(3y)2.52%
ROA(5y)0.87%
ROE(3y)13.51%
ROE(5y)4.58%
ROIC(3y)2.99%
ROIC(5y)N/A
SPNT Yearly ROA, ROE, ROICSPNT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20

1.3 Margins

  • SPNT's Profit Margin of 13.88% is fine compared to the rest of the industry. SPNT outperforms 75.84% of its industry peers.
  • SPNT's Profit Margin has declined in the last couple of years.
  • SPNT has a Operating Margin (12.64%) which is in line with its industry peers.
  • In the last couple of years the Operating Margin of SPNT has declined.
Industry RankSector Rank
OM 12.64%
PM (TTM) 13.88%
GM N/A
OM growth 3YN/A
OM growth 5Y-8.48%
PM growth 3YN/A
PM growth 5Y-2.88%
GM growth 3YN/A
GM growth 5YN/A
SPNT Yearly Profit, Operating, Gross MarginsSPNT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40 -60 -80

1

2. SPNT Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SPNT is destroying value.
  • The number of shares outstanding for SPNT has been increased compared to 1 year ago.
  • SPNT has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for SPNT is higher compared to a year ago.
SPNT Yearly Shares OutstandingSPNT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
SPNT Yearly Total Debt VS Total AssetsSPNT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • The Debt to FCF ratio of SPNT is 6.72, which is on the high side as it means it would take SPNT, 6.72 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of SPNT (6.72) is worse than 65.77% of its industry peers.
  • A Debt/Equity ratio of 0.28 indicates that SPNT is not too dependend on debt financing.
  • SPNT has a Debt to Equity ratio (0.28) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 6.72
Altman-Z N/A
ROIC/WACC0.31
WACC9.05%
SPNT Yearly LT Debt VS Equity VS FCFSPNT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
SPNT Yearly Current Assets VS Current LiabilitesSPNT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

5

3. SPNT Growth Analysis

3.1 Past

  • SPNT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 284.38%, which is quite impressive.
  • The Earnings Per Share has been growing by 19.73% on average over the past years. This is quite good.
  • SPNT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.72%.
  • The Revenue has been growing by 29.21% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)284.38%
EPS 3YN/A
EPS 5Y19.73%
EPS Q2Q%1615.38%
Revenue 1Y (TTM)14.72%
Revenue growth 3Y15.03%
Revenue growth 5Y29.21%
Sales Q2Q%8.91%

3.2 Future

  • Based on estimates for the next years, SPNT will show a decrease in Earnings Per Share. The EPS will decrease by -5.53% on average per year.
  • Based on estimates for the next years, SPNT will show a small growth in Revenue. The Revenue will grow by 6.13% on average per year.
EPS Next Y-31.59%
EPS Next 2Y-13.61%
EPS Next 3Y-5.53%
EPS Next 5YN/A
Revenue Next Year9.12%
Revenue Next 2Y7.47%
Revenue Next 3Y6.13%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SPNT Yearly Revenue VS EstimatesSPNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
SPNT Yearly EPS VS EstimatesSPNT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 -2

5

4. SPNT Valuation Analysis

4.1 Price/Earnings Ratio

  • SPNT is valuated cheaply with a Price/Earnings ratio of 5.59.
  • Based on the Price/Earnings ratio, SPNT is valued cheaper than 80.54% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.25, SPNT is valued rather cheaply.
  • The Price/Forward Earnings ratio is 8.16, which indicates a very decent valuation of SPNT.
  • Based on the Price/Forward Earnings ratio, SPNT is valued a bit cheaper than 65.10% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of SPNT to the average of the S&P500 Index (24.39), we can say SPNT is valued rather cheaply.
Industry RankSector Rank
PE 5.59
Fwd PE 8.16
SPNT Price Earnings VS Forward Price EarningsSPNT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 72.48% of the companies in the same industry are more expensive than SPNT, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, SPNT is valued a bit more expensive than 69.80% of the companies in the same industry.
Industry RankSector Rank
P/FCF 23.55
EV/EBITDA 5.71
SPNT Per share dataSPNT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • SPNT's earnings are expected to decrease with -5.53% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.28
EPS Next 2Y-13.61%
EPS Next 3Y-5.53%

0

5. SPNT Dividend Analysis

5.1 Amount

  • No dividends for SPNT!.
Industry RankSector Rank
Dividend Yield 0%

SPNT Fundamentals: All Metrics, Ratios and Statistics

SIRIUSPOINT LTD

NYSE:SPNT (3/10/2026, 8:04:00 PM)

After market: 20.61 0 (0%)

20.61

-0.1 (-0.48%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)02-18
Earnings (Next)05-04
Inst Owners87.35%
Inst Owner Change0.65%
Ins Owners1.51%
Ins Owner Change6.07%
Market Cap2.41B
Revenue(TTM)3.19B
Net Income(TTM)443.20M
Analysts80
Price Target23.97 (16.3%)
Short Float %2.16%
Short Ratio3.3
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.14
Dividend Growth(5Y)N/A
DP3.61%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)145.75%
Min EPS beat(2)40.33%
Max EPS beat(2)251.16%
EPS beat(4)3
Avg EPS beat(4)96.65%
Min EPS beat(4)-13.77%
Max EPS beat(4)251.16%
EPS beat(8)5
Avg EPS beat(8)36.31%
EPS beat(12)9
Avg EPS beat(12)70.01%
EPS beat(16)9
Avg EPS beat(16)13.97%
Revenue beat(2)2
Avg Revenue beat(2)7.2%
Min Revenue beat(2)1.17%
Max Revenue beat(2)13.24%
Revenue beat(4)2
Avg Revenue beat(4)-1.54%
Min Revenue beat(4)-11.21%
Max Revenue beat(4)13.24%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.44%
PT rev (3m)4.44%
EPS NQ rev (1m)1.47%
EPS NQ rev (3m)1.47%
EPS NY rev (1m)2.27%
EPS NY rev (3m)1.43%
Revenue NQ rev (1m)-5.72%
Revenue NQ rev (3m)-5.72%
Revenue NY rev (1m)2.81%
Revenue NY rev (3m)3.56%
Valuation
Industry RankSector Rank
PE 5.59
Fwd PE 8.16
P/S 0.75
P/FCF 23.55
P/OCF 23.55
P/B 0.98
P/tB 1.03
EV/EBITDA 5.71
EPS(TTM)3.69
EY17.9%
EPS(NY)2.52
Fwd EY12.25%
FCF(TTM)0.88
FCFY4.25%
OCF(TTM)0.88
OCFY4.25%
SpS27.3
BVpS21.11
TBVpS20.08
PEG (NY)N/A
PEG (5Y)0.28
Graham Number41.87
Profitability
Industry RankSector Rank
ROA 3.53%
ROE 17.94%
ROCE 3.22%
ROIC 2.76%
ROICexc 2.94%
ROICexgc 3.94%
OM 12.64%
PM (TTM) 13.88%
GM N/A
FCFM 3.21%
ROA(3y)2.52%
ROA(5y)0.87%
ROE(3y)13.51%
ROE(5y)4.58%
ROIC(3y)2.99%
ROIC(5y)N/A
ROICexc(3y)3.19%
ROICexc(5y)N/A
ROICexgc(3y)4.35%
ROICexgc(5y)N/A
ROCE(3y)3.48%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-5.06%
ROICexc growth 3YN/A
ROICexc growth 5Y-10.15%
OM growth 3YN/A
OM growth 5Y-8.48%
PM growth 3YN/A
PM growth 5Y-2.88%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 6.72
Debt/EBITDA 1.66
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 5.17
Cash Conversion 24.7%
Profit Quality 23.1%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score7
WACC9.05%
ROIC/WACC0.31
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)79.02%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)284.38%
EPS 3YN/A
EPS 5Y19.73%
EPS Q2Q%1615.38%
EPS Next Y-31.59%
EPS Next 2Y-13.61%
EPS Next 3Y-5.53%
EPS Next 5YN/A
Revenue 1Y (TTM)14.72%
Revenue growth 3Y15.03%
Revenue growth 5Y29.21%
Sales Q2Q%8.91%
Revenue Next Year9.12%
Revenue Next 2Y7.47%
Revenue Next 3Y6.13%
Revenue Next 5YN/A
EBIT growth 1Y-19.49%
EBIT growth 3YN/A
EBIT growth 5Y18.26%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y37.08%
FCF growth 3Y-29.59%
FCF growth 5Y6.89%
OCF growth 1Y37.08%
OCF growth 3Y-29.59%
OCF growth 5Y6.89%

SIRIUSPOINT LTD / SPNT FAQ

What is the fundamental rating for SPNT stock?

ChartMill assigns a fundamental rating of 3 / 10 to SPNT.


What is the valuation status for SPNT stock?

ChartMill assigns a valuation rating of 5 / 10 to SIRIUSPOINT LTD (SPNT). This can be considered as Fairly Valued.


Can you provide the profitability details for SIRIUSPOINT LTD?

SIRIUSPOINT LTD (SPNT) has a profitability rating of 4 / 10.


How financially healthy is SIRIUSPOINT LTD?

The financial health rating of SIRIUSPOINT LTD (SPNT) is 1 / 10.


What is the earnings growth outlook for SIRIUSPOINT LTD?

The Earnings per Share (EPS) of SIRIUSPOINT LTD (SPNT) is expected to decline by -31.59% in the next year.